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Interleukin-1α (IL-1α) and its receptor antagonist 
IL-1RA play a pivotal role in skin homeostasis and di-
sease. Although the use of biopsies to sample these 
cytokines from human skin is widely employed in der-
matological practice, knowledge about less invasive, 
in vivo sampling methods is scarce. The aim of this 
study was to provide an overview of such methods by 
systematically reviewing studies in Medline, EMBASE, 
Web of Science and Cochrane Library using combina-
tions of the terms “IL-1α”, IL-1RA”, “skin”, “human”, 
including all possible synonyms. Quality was assessed 
using the STrengthening the Reporting of OBservatio-
nal studies in Epidemiology (STROBE) checklist. The 
search, performed on 14 October 2016, revealed 10 
different sampling methods, with varying degrees of 
invasiveness and wide application spectrum, including 
assessment of both normal and diseased skin, from 
several body sites. The possibility to sample quantifi-
able amounts of cytokines from human skin with no or 
minimal discomfort holds promise for linking clinical 
outcomes to molecular profiles of skin inflammation. 
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The primary function of the skin is to provide a physical barrier between the internal milieu and the 
external environment (1, 2). In addition, the skin was 
more recently recognized to have strong immunological 
role (3). Keratinocytes and resident skin cells, such as 
fibroblasts, mast cells, Langerhans cells and other der-
mal dendritic cells, have been shown to release a wide 
variety of mediators, both in the maintenance of tissue 
homeostasis (immune-surveillance) as well as in case of 
injury or pathogen invasion (4). Among the most cha-
racterized mediators are interleukins (IL) belonging to 
the IL-1 family, namely IL-1α, IL-1β and their receptor 
antagonist IL-1RA (5). These cytokines are among the 
first mediators to be released in acute or chronic skin in-
flammation and are involved in a wide spectrum of (skin) 
diseases (4, 5). In this respect, blocking IL-1 activity for 
therapeutic purposes has entered clinical practice (6). Of 
note, unlike IL-1β, IL-1α and IL-1RA have also been 
shown to be detectable in normal skin (4).
Evidence for the presence of biologically active IL-1 in 
normal epidermis and stratum corneum (SC) emerged in 
the mid 1980s by means of bioassays, which measured the 
ability of IL-1 to augment proliferation of specific cell lines 
(e.g. murine thymocytes in the thymocyte co-stimulation 
assay) or to stimulate release of collagenase or prostaglan-
din from human dermal fibroblasts (7, 8). Bioassays were 
limited by the impossibility of discriminating between IL-
1α and IL-1β as well as between IL-1 and other cytokines 
(9), prompting some authors to cautiously refer to their 
findings as IL-1 or IL-1α “like” material (10). In the late 
1980s these obstacles were overcome by the advent of mo-
noclonal antibodies against IL-1α and IL-1β, allowing the 
2 isoforms to be determined and distinguished with high 
sensitivity and specificity (9). Since then, enzyme immu-
noassays (EIA) and enzyme-linked immunosorbent assays 
(ELISA) have become widely used for the evaluation of 
soluble analytes in biological samples (11, 12). The major 
shortcomings of ELISA are that it allows the measurement 
of only one analyte at a time in a given sample and that 
it requires relatively large sample amounts (typically 100 
µl) (13). Building on the principles of ELISA, in the late 
1990s multiplex arrays were introduced with the purpose 
of measuring multiple analytes in the same sample at the 
same time (13, 14). An example is constituted by mul-
tiplex bead-based assays, in which sets of microscopic 
colour-coded beads (microspheres) coated with capture 
antibodies for specific analytes are simultaneously used 
(13, 14). By flow cytometric analysis, the signal coming 
from the different bead sets can be distinguished and the 
binding events between the detection antibodies and the 
analyte-capture antibody complex on each bead set can 
be quantified (13, 14). Comparability analyses between 
ELISA and multiplex bead-based assays yielded positive 
results (15). 
Given the relevance of IL-1 in skin homeostasis and 
disease, different sampling methods, followed by the 
above-mentioned immunoassay quantifications, have 
been reported to analyse it. While taking skin biopsies 
remains the most widely used approach in clinical prac-
tice, successful attempts using less invasive sampling 
methods have been reported. The aim of this study was 
to provide an overview of such minimally invasive 
methods by systematically reviewing studies in which 
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IL-1α and/or IL-1RA were sampled from the skin of 
human volunteers in vivo. The choice was restricted to 
these 2 mediators because of their constitutive presence 
both in normal and diseased skin and their clinical re-
levance (4–6). For each method, applications as well as 
advantages and shortcomings were highlighted. We hope 
that this review will increase awareness of the additional 
insights offered by analysis of local skin inflammation at 
the molecular level and will foster research towards im-
plementation of minimally-invasive biomarker analysis 
in dermatological practice.
METHODS
An extensive literature search was performed on 14 October 
2016 in 4 computerized bibliographical databases: Medline, 
EMBASE, Web of Science and the Cochrane Library. Medical 
Subject Heading and free-text searches embracing the following 
terms were used: “interleukin 1 alpha”, “interleukin 1 receptor 
antagonist”, “skin”, “human”, including all possible abbreviations 
and synonyms. The complete search strategy is shown in Table 
SI1. The literature search was limited to publications in English. 
No date restrictions applied. 
The article selection process followed 3 steps. In step one, a first 
screening was performed by one reviewer (DF) in which titles and 
abstracts, and materials and methods when the abstract was not 
available, were reviewed for relevance, taking into account a list of 
exclusion criteria. In case of uncertainty or if none of the exclusion 
criteria were met, in step 2 a second screening was performed in 
which the full text was retrieved and inclusion judged by 2 inde-
pendent reviewers (DF and PvE) on the basis of a list of inclusion 
criteria. Consensus on inclusion was reached by discussion. In 
step 3, the reference lists of the eligible studies were additionally 
screened to ensure that all relevant studies were included. The 
schematic representation of the article selection process and the list 
of exclusion and inclusion criteria is shown in Fig. S11.
The methodological quality of the included studies was assessed 
by the STrengthening the Reporting of OBservational studies in 
Epidemiology (STROBE) criteria: each study received, indepen-
dently by the 2 reviewers (DF and PvE), a score ranging from 0 
to 22, which was then expressed as a percentage of the maximum 
score (16). Depending on the level of fulfilment of the criteria 
stated in STROBE, articles were categorized as A (> 80%), B 
(60–80%) or C (< 60%). When scores differed by more than 1.5, 
consensus was reached by discussion. 
RESULTS
Article selection and quality
The search in the 4 bibliographical databases revealed a 
total of 6,598 hits. After exclusion of duplicates and of 
articles meeting any of the exclusion criteria in the first 
screening, 535 articles remained for full-text evaluation. 
For most articles, the exclusion criteria from the first 
screening applied following full-text evaluation. Four 
articles for which the inclusion criteria applied were 
excluded because of the lack of description of the human 
volunteers from which the skin material was taken or 
of the method used to obtain the skin material. Manual 
screening of the reference lists resulted in the inclusion 
of one more article. In total, 63 articles were included 
in this review. The number of articles at each step of the 
selection process are shown in Fig. S21. 
Article quality was, on average, good: 8 articles were 
classified as a category C (score < 60%), 47 articles 
were classified as a category B (score 60–80%) and the 
remaining 8 articles were classified as a category A (score 
> 80%). Shortcomings were mainly related to the lack of 
description of potential confounders and effect modifiers 
concerning the study participants (e.g. age, skin type) or 
the sampling procedure (e.g. season and experimental 
conditions in which the sampling was performed). In 
addition, only a few studies specified the number of 
participants included at each stage. The STROBE as-
sessment for each article included in the review can be 
requested from the corresponding author. 
Each sampling technique is presented in the following 
paragraphs. An overview of each technique, including 
collection time, applications, advantages and short-
comings is shown in Table I. A detailed summary of each 
study included in this review can be requested from the 
corresponding author. 
Tape stripping
The majority of articles (n = 24) sampled IL-1α and/or IL-
1RA using tape stripping. This technique was characteri-
zed by a high heterogeneity in the sampling procedure. 
Unfortunately, only a few articles thoroughly described 
the sampling procedure by specifying the type, area and 
number of adhesive tapes used, the application time of 
each tape on the skin, and whether constant pressure was 
applied, all variables known to influence the procedure 
(17). For the quantification of the protein levels of IL-1α 
and/or IL-1RA, the majority used EIA/ELISA (n = 16) 
(18–33) and the remaining used multiplex arrays (34–41). 
Concomitantly to the analysis of IL-1α and/or IL-1RA, 9 
articles used tape stripping to sample additional cytokines 
and chemokines (20–23, 34, 36–38, 40). The additional 
measurement of the total protein content on the tapes 
was used as a biomarker of the cohesiveness of the SC 
(20, 27, 36, 40, 41). 
Among the advantages of tape stripping, the minimal 
invasiveness and the short duration of the procedure 
were mentioned (19, 20), suggesting that the cytokine 
amounts are hardly influenced by the sampling process 
(20). Among the drawbacks, the fact that in normal SC 
only IL-1α and IL-1RA are present in sufficient amounts 
for routine cytokine determination (19). In agreement 
with this, some articles reported that other cytokines 
and chemokines were not or rarely detected (21–23, 
34). Moreover, a study of de Jongh et al. evaluated the 
distribution of IL-1α and IL-1RA in the SC, showing 
that, while in normal SC the distribution does not change 
with depth, after perturbation with chemical substances 1https://www.medicaljournals.se/acta/content/abstract/10.2340/00015555-2709
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it changes significantly (20). The authors concluded that, 
in the study of irritated or diseased skin, it would be 
better to sample the whole SC. Observations about the 
variability of amounts across the SC were also reported 
in other studies (32, 40).
Skin suction blistering
The second most widespread method to sample IL-1α 
and/or IL-1RA was based on skin suction blistering 
(n = 15). In this technique, introduced by Kiistala in the 
1960s (42), the viable epidermis is separated from the 
dermis by application of negative pressure, resulting in 
the generation of artificial blisters. In the articles included 
in this review, the negative pressure was between 200 and 
400 mmHg, the suction cups ranged in size from 5 to 15 
mm and the time needed for the formation of the blisters 
was mostly 2–3 h. Warming was sometimes added to aid 
blister formation. For the quantification of the protein 
levels of IL-1α and/or IL-1RA, the majority used EIA/
ELISA (n = 10) (43–52) and the remaining used multi-
plex arrays (53–57). All studies but 2 analysed additional 
cytokines and chemokines, albeit many reported that not 
all could be detected (43–45, 51, 52, 54, 55). 
The advantage offered by the assessment of the local 
inflammatory profile in the suction blister fluid (54, 55) 
was counterbalanced by the suggestion that the local 
trauma caused by the suction process might induce cy-
tokines release and formation, thereby influencing the 
measured amounts (46–48, 50). Other reported issues 
included the cumbersomeness of the technique (56), 
the possibility of pain during the procedure (57) and the 
possibility of blood contamination of the blister (52). 
Adsorption by Sebutape
The third most common method consisted in the adsorp-
tion of IL-1α and/or IL-1RA from the skin surface by 
Table I. Overview of the minimally-invasive techniques to sample interleukin (IL)-1α and/or IL-1RA from the skin of human volunteers 
in vivo
Method n
Collection 
time
Body site(s) 
in which collection 
was performed Applications
IL-1α and/
or IL-1RA 
detectable?
Other 
biomarkers 
detectable? Advantages Shortcomings
Tape stripping 24 Few 
minutes
Forearm, neck, scalp, 
cheek, forehead, 
hand, sole, upper arm, 
trunk, leg, vulvar area, 
buttock
Healthy skin, 
diseased skin 
(dandruff, SeD, AD, 
psoriasis, CICD, 
acne, senile xerosis)
Yes Variable Short collection time
Possibility to sample the 
distribution of biomarkers 
in the SC
Influence of several 
collection parameters 
on the outcome (e.g. 
pressure, type of tape)
Skin suction 
blistering
15 2–3 h Forearm, hand, trunk, 
leg, buttock
Healthy skin, 
diseased skin (AD, 
psoriasis, SSc, PLE, 
BP, CRPS1)
Yes Variable Biomarkers in the blister 
fluid possibly more 
representative of the 
amount in the skin than 
biomarkers at the surface 
Long collection time
Cumbersome
Possibility of pain/blood 
contamination
Collected biomarkers 
possibly influenced by 
skin trauma
Adsorption by 
Sebutape
9 1–2 min Forearm, scalp, cheek, 
forehead, upper arm, 
trunk, leg, buttock 
Healthy skin, 
diseased skin 
(dandruff, SeD, 
rosacea, striae 
distensae, diaper 
dermatitis)
Yes Variable Short collection time Influence of sebum
Only biomarkers at 
the skin surface are 
collected
Skin chamber 
technique
4 3–24 h Forearm Healthy skin Yes Variable In vivo model of cutaneous 
inflammation
Long collection time
Cumbersome
Possibility of pain
Microporation 3 3–4 h Forearm Healthy skin, 
diseased skin (AD)
Yes Variable Biomarkers in the 
transdermal fluid possibly 
more representative of the 
amount in the skin than 
biomarkers at the surface
Long collection time
Collected biomarkers 
possibly influenced by 
skin trauma
More data on the 
efficiency of transdermal 
fluid collection and on 
the depth of micropores 
needed
Swabbing 3 Few 
seconds
Scalp, arm, leg Healthy skin, 
diseased skin (SeD, 
AD)
Yes Variable Short collection time Only biomarkers at 
the skin surface are 
collected
Skin surface 
wash sampling
2 30 min Arm Healthy skin, 
diseased skin (AD, 
psoriasis)
Yes Variable Average collection time Only biomarkers at 
the skin surface are 
collected
Microdialysis 1 1.5 h Forearm Healthy skin Yes Variable Biomarkers in the 
dialysate possibly more 
representative of the 
amount in the skin than 
biomarkers at the surface 
Long collection time
Collected biomarkers 
possibly influenced by 
skin trauma
Local anaesthesia 
needed
Scraping 1 Few 
minutes
Elbow Healthy skin, 
diseased skin 
(psoriasis)
Yes Variable Short collection time Poor control on the 
amount of SC removed
Transdermal 
analyses patch
1 20 min Forearm, neck, cheek Healthy skin Yes Variable Average collection time Only biomarkers at 
the skin surface are 
collected
AD: atopic dermatitis; BP: bullous pemphigoid; CICD: chronic irritant contact dermatitis; CRPS1: complex regional pain syndrome type 1; PLE: polymorphic light eruption; 
SeD: seborrhoeic dermatitis; SC: stratum corneum; SSc: systemic sclerosis.
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means of a lipophilic tape, Sebutape (CuDerm, Dallas, 
TX, USA) (n = 9). Sebutape, originally developed for 
extraction of sebum from the skin, was demonstrated by 
Perkins et al. to be able to recover quantifiable levels of 
inflammatory proteins from normal skin (58). All articles 
used ELISA to quantify the protein levels of IL-1α and/
or IL-1RA (58–65), except one which used a multiplex 
array (66). In addition to the measurement of IL-1α and/
or IL-1RA, 4 articles sampled additional cytokines and 
chemokines (58, 63, 64, 66). However, authors reported 
that some of these additional biomarkers were frequently 
extremely low or not detected. 
The minimal-invasiveness of the method was demon-
strated by Perkins et al. by analysing the impact of 30 se-
quential applications of Sebutape on the skin and finding 
no upregulation of IL-1α nor IL-8, another inflammatory 
cytokine, up to 24 h after stimulation (58). However, the 
same author warned about the problem of sebum depo-
sition on the tape, which could compete with IL-1α for 
adsorption. As a consequence, all articles employing this 
method used short (1–2 min) collection times. 
Skin chamber technique
Four articles sampled IL-1α and/or IL-1RA using a skin 
chamber technique. This technique, developed from the 
skin suction blistering method, was used as in vivo model 
to study the cutaneous inflammatory response in humans 
and, specifically, the dynamics of leukocyte migration 
(67). In this procedure, after removal of the blister roof 
obtained by application of negative pressure, the denuded 
dermis (“skin window”) is covered by a chamber contain-
ing a medium capable to induce a chemotactic response 
(mostly autologous serum) (67). All articles included in 
this review collected the skin chamber fluid between 3 
and 24 h after removal of the blister roofs and, besides 
IL-1α and/or IL-1RA, used ELISA to analyse additional 
cytokines and chemokines (68–71). 
Microporation
Three articles used microporation to sample IL-1α and/
or IL-1RA. In this technique, an infrared laser is used 
to generate micropores (approximately 100 µm wide) 
up to the first tens of µm in the epidermis. Transdermal 
fluid (TDF) is then collected by application of negative 
pressure similarly to the skin suction blistering technique 
(around 300 mmHg for 3–4 h). One article analysed 
IL-1α with ELISA and IL-1RA with a multiplex array 
(72), whereas the others used only multiplex arrays (73, 
74). All studies also assessed additional cytokines and 
chemokines, but reported that some were extremely low 
or not detected. 
While being less invasive than the skin blistering 
technique, as impact on the integrity of the tissue is re-
latively minor (74), concerns arise about the collection 
efficiency of TDF, since in one out of 9 volunteers (72), 
7 out of 28 volunteers (73) and 6 out of 16 volunteers 
(74) collection of TDF failed or was too low. The pos-
sible impact of the procedure on the measured amounts 
of cytokines should be considered, and additional data 
on the reproducibility of the depth of the laser-generated 
micropores would be needed. 
Swabbing
Three articles sampled IL-1α and/or IL-1RA by swabbing 
the skin with cotton-tipped swabs or cotton buds impreg-
nated with a solution of saline and Triton to lyse cells 
and extract proteins. All articles used ELISA to analyse 
IL-1α and/or IL-1RA together with other cytokines and 
chemokines (75–77). 
Skin surface wash sampling
Two articles sampled IL-1α and IL-1RA by means of skin 
surface wash. In this technique, proposed by Portugal-
Cohen et al. (78), a small well is attached to the skin by 
an adhesive pad and is filled with 0.5–1 ml extraction 
buffer consisting of phosphate-buffered saline (PBS), pH 
approximately 7. After sealing, the well is left on the skin 
for a 30-min incubation time. Collected samples were 
analysed with ELISA in the study of Portugal-Cohen et 
al. (78) and with multiplex arrays with varying detecta-
bility levels in a more recent study (79). 
The advantage of the method relies on its minimal 
invasiveness, whereas its drawback is the relatively long 
incubation time (80). Moreover, the extraction buffer is 
only suitable to extract hydrophilic compounds; lipophi-
lic compounds could be sampled using a more suitable 
extraction buffer containing surfactants (80). 
Of note, a similar version of this method (though de-
fined as a “skin chamber technique”) was used by Reilly 
et al. to sample biomarkers from tape-stripped skin (48). 
Yields of IL-1α increased by increasing the incubation 
time and the number of tape strips. 
Microdialysis
One study used microdialysis to sample IL-1α and other 
biomarkers and quantified them by multiplex array (81). 
Two linear semi-permeable membranes were inserted 
into the volar forearm of healthy volunteers at a depth 
of 0.7 mm for a length of 20 mm. Upon onset of probe 
perfusion with buffer, extracellular molecules would 
diffuse through the membranes into the probe lumen to 
be collected in the exiting fluid (dialysate). Dialysate 
collection lasted for 30 min and was performed at ba-
seline and at several time-points following intradermal 
injection of allergen. 
Although almost all biomarkers could be detected 
following allergen injection, the use of microdialysis for 
sampling large proteins, such as cytokines, is challenging 
(82). In order to increase relative recovery, an in-house 
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membrane with molecular mass cut-off of 3000 kDa 
was used, much higher than the molecular mass cut-off 
of 100 kDa usually employed in commercially available 
membranes for cytokine sampling (82, 83). This can 
expose the membranes to ultrafiltration, possibly cau-
sing significant loss of dialysate (82, 83). Other effects 
potentially hampering the recovery rate of cytokines in 
microdialysis include low analyte concentration in the 
extracellular milieu and the adsorption onto the polyme-
ric materials used to construct the membranes and the 
outlet probe (82, 83). Finally, commonly to skin suction 
blistering and microporation, the trauma to the skin due 
to probe insertion and the possible effect on the measured 
amounts of biomarkers should be considered. 
Scraping
In one article, delicate scraping with a surgical blade was 
used to obtain extracts of SC from healthy volunteers 
and scales from plaques of patients with psoriasis (84). 
Samples of 10 mg were homogenized in PBS and levels 
of IL-1RA and other biomarkers were subsequently 
analysed with a multiplex array. 
Transdermal analyses patch
A novel method to sample IL-1α and IL-1RA from the 
skin surface was introduced by Orro et al. (85). In this 
method, a transdermal analyses patch (TAP) is attached 
to the skin by means of a dermal adhesive plaster. On the 
side in contact with the skin, the patch contains a circular 
nitrocellulose micro-array (5 mm in diameter) coated 
with antibodies for 4 different protein biomarkers. On the 
upper side, covering the micro-array, a reservoir allows 
addition of a standardized amount of buffer (PBS at pH 
7.3) for biomarker extraction and ensures close contact 
between the micro-array and the skin. In the study of Orro 
et al., following optimization of the protein capture and 
detection protocols, 20 min resulted a suitable incubation 
time for biomarkers extraction. After removal of TAP, 
biomarkers were analysed using ELISA. 
In the same study, authors compared the biomarkers 
yield of TAP and of the skin surface wash sampling met-
hod, showing higher yield of proteins for the former. They 
suggested that the higher sensitivity of TAP might be due 
to higher concentration of proteins in the buffer, or to pos-
sible degradation of analytes in skin surface wash. Also 
Reilly et al., using a similar version of skin surface wash, 
suggested that the reason why some mediators could 
not be detected could be dilution of the small amount of 
inflammatory exudates in a large volume of PBS (48).
DISCUSSION
The primary objective of this study was to systematically 
review minimally-invasive methods whereby the pro-
inflammatory cytokine IL-1α and its receptor antagonist 
IL-1RA were sampled from the skin of human volunteers 
in vivo, and subsequently analysed at the protein level 
by means of immunoassays. 
Ten different methods were found. Common to all 
methods was the possibility to assess, in addition to 
IL-1α and/or IL-1RA, other biomarkers including pro-
inflammatory cytokines, anti-inflammatory cytokines, 
chemokines and various growth factors. Since not every 
article explicitly mentioned if IL-1α, IL-1RA or the other 
biomarkers were measurable in all samples, a comparison 
of the different methods based on the detectability level 
of the collected biomarkers was not possible. As a gene-
ral trend, IL-1α and IL-1RA were often or consistently 
measurable, whereas the other biomarkers were some-
times rarely or not detectable. Possible reasons could be 
absence in the epidermis, low production or production 
in different time courses, rapid uptake by target cells, 
and insufficient sensitivity of the assay (21, 48, 55, 58, 
74, 81). Another frequently reported aspect was the large 
inter-subject variability in the biomarkers amounts (21, 
32, 36, 43, 45–47, 56, 58, 63, 64, 72, 73, 81), for which 
authors resorted to non-parametric statistical analyses or 
to log-transformation of the data. 
The balance between the expression levels of cyto-
kines of the IL-1 family is decisive in the generation 
of pro-inflammatory and homeostatic functions (5). In 
particular, the ratio between IL-1RA and IL-1α can be 
used to assess skin inflammation (4). Compared with 
healthy volunteers, an increase in the IL-1RA/IL-1α ratio 
was observed in patients with inflammatory skin diseases 
including psoriasis, atopic dermatitis (AD), dandruff, 
seborrhoeic dermatitis and rosacea (32, 36, 63, 64, 75). 
This indicates that the increased ratio could be considered 
a non-specific hallmark of various kinds of inflammation 
(32, 36, 63), and might reflect an attempt to downregulate 
the inflammatory response (64). This is supported by a 
decrease in the levels of IL-1α and in the IL-1RA/IL-1α 
ratio observed after topical treatments (18, 25, 27, 32, 35, 
36, 39, 75, 77) and by a decreased IL-1α expression found 
in full-thickness biopsy specimens of psoriatic skin (86). 
The ratio might also highlight differential expression of 
inflammatory markers following different modalities of 
skin irritation, since an increased ratio compared with nor-
mal skin was observed after repeated exposure to sodium 
dodecyl sulphate (SLS) (21, 72) and a lower ratio was 
reported after single exposure to SLS (58) or after tandem 
exposure to SLS and another irritant (34). Interestingly, 
an increased ratio could distinguish also non-lesional skin 
in patients with AD, psoriasis and rosacea from skin of 
healthy volunteers (32, 64), as well as sun-exposed skin 
on the face compared with unexposed skin (23, 32, 58, 
85). This suggests that inflammatory changes might be 
present even in normal-appearing skin and supports what 
Professor Kligman called invisible dermatoses (87).
Among the extrinsic factors possibly affecting the 
recovered amounts of IL-1α and IL-1RA figure season, 
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since a lower IL-1RA/IL-1α ratio was found in summer 
compared with winter (41), and UV exposure, since 
release of IL-1α and/or IL-1RA was observed following 
UV irradiation (23, 43, 56, 73). These factors indicate 
that data collection and skin phototype (e.g. Fitzpatrick 
skin type) should be specified, as they might constitute 
potential confounders. In addition, the presence of IL-
1α in sweat (22) and the increased expression of IL-1α 
at low humidity (88) suggest that the temperature and 
relative humidity of the experimental room should be 
standardized, as for measurements with bioengineering 
techniques (89–91). Among the intrinsic factors, con-
flicting results emerged for sex, since differences were 
found in one study (19) and not in others (28, 35), as well 
as for age, since an effect was observed in some studies 
(23, 79) and not in others (31, 34). In the particular case 
of infant skin, higher IL-1α levels without concomitant 
signs of inflammation were found in neonates compared 
with adults (38) and at one-month post-partum compa-
red with birth (62), suggesting that, for this specific age 
group, IL-1α might be used as a biomarker of skin barrier 
maturation (62).
The limitation of this study is that the restriction of 
the search strategy to IL-1α and IL-1RA could have 
excluded minimally-invasive methods used to sample 
other biomarkers. The addition of relevant cytokines 
and chemokines, such as IL-1β, IL-6 and IL-8 (4) would 
have strengthened and, possibly, broadened the overview 
of minimally-invasive sampling methods; on the other 
hand, it would have also complicated the search strategy 
and prolonged the article selection process. Despite this 
obvious limitation, we believe that the relevance of the 
chosen biomarkers and the systematic article selec-
tion process maintain the validity of the overview of 
minimally-invasive methods presented in this review. 
In conclusion, this review showed that several methods 
are available to collect quantifiable amounts of IL-1α, 
IL-1RA and other biomarkers from the skin, causing no 
or minimal discomfort. This is relevant on both practi-
cal and ethical grounds. Whereas it might be possible 
to argue that the levels of biomarkers measured in the 
fluid extracted by skin suction blistering, microporation 
and microdialysis are more representative of the overall 
levels present in the skin, the long collection time and the 
relative invasiveness make them less practical for use in 
routine testing. Tape stripping, adsorption with Sebutape, 
swabbing, skin surface wash sampling, scraping and 
TAP, characterized by shorter collection time and lower 
invasiveness, would be more fit for that purpose. Ho-
wever, it needs to be realized that these methods sample 
biomarkers at the skin surface, and that surface levels 
do not necessarily correspond to the ones in deeper skin 
layers. Independently of the method used, assessing the 
individual cytokine profile locally in the skin would bring 
additional insights than assessing it only systemically in 
blood (54, 55, 69, 81). We strongly encourage performing 
clinical investigations to gain further insights into the 
relationship between clinical responses and biomarkers 
at the molecular level. This will hopefully lead to im-
plementation of these minimally-invasive methods in 
clinical practice to target and monitor therapies, predict 
disease progression and response to treatment.
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